Authors:
Fiter, J
Nolla, JM
Navarro, MA
Gomez-Vaquero, C
Rosel, P
Mateo, L
Roig-Escofet, D
Citation: J. Fiter et al., Weak androgen levels, glucocorticoid therapy, and bone mineral density in postmenopausal women with rheumatoid arthritis, JOINT BONE, 67(3), 2000, pp. 199-203
Authors:
Rosel, P
Arranz, B
San, L
Vallejo, J
Crespo, JM
Urretavizcaya, M
Navarro, MA
Citation: P. Rosel et al., Altered 5-HT2A binding sites and second messenger inositol trisphosphate (IP3) levels in hippocampus but not in frontal cortex from depressed suicidevictims, PSYCH RES-N, 99(3), 2000, pp. 173-181
Authors:
Martinez-Carpio, PA
Mur, C
Rosel, P
Navarro, MA
Citation: Pa. Martinez-carpio et al., Constitutive and regulated secretion of epidermal growth factor and transforming growth factor-beta(1) in MDA-MB-231 breast cancer cell line in 11-day cultures, CELL SIGNAL, 11(10), 1999, pp. 753-757
Authors:
Rosel, P
Arranz, B
San, L
Urretavizcaya, M
Marcusson, J
Navarro, MA
Citation: P. Rosel et al., 5-HT2A receptors and their second messenger IP3 are only correlated in human brain and not in platelets., NEUROSC R C, 25(3), 1999, pp. 129-138
Authors:
Rosel, P
Arranz, B
Oros, M
Vallejo, J
San, L
Marcusson, J
Navarro, MA
Citation: P. Rosel et al., Different regional distribution of the 5-HT reuptake complex, the 5-HT2A receptors and their second messenger IP3 in human brain., NEUROSC R C, 24(2), 1999, pp. 107-115
Authors:
Martinez-Carpio, PA
Mur, C
Fernandez-Montoli, ME
Ramon, JM
Rosel, P
Navarro, MA
Citation: Pa. Martinez-carpio et al., Secretion and dual regulation between epidermal growth factor and transforming growth factor-beta(1) in MDA-MB-231 cell line in 42-hour-long cultures, CANCER LETT, 147(1-2), 1999, pp. 25-29
Authors:
Rosel, P
Arranz, B
Vallejo, J
Alvarez, P
Menchon, JM
Palencia, T
Navarro, MA
Citation: P. Rosel et al., Altered [H-3]imipramine and 5-HT2 but not [H-3]paroxetine binding sites inplatelets from depressed patients, J AFFECT D, 52(1-3), 1999, pp. 225-233